Fun With Pharma ETFs

It is not hyperbole to say 2013 was the year of the health care exchange trade fund. Multiple anecdotes prove the point. Not only was the Health Care Select Sector SPDR (NYSEArca: XLV) the second-best of the nine sector SPDRs, but four biotechnology funds were among 2013’s 10 best non-leveraged...